GLP-1 medicines were a key part of the update. Sigma said the business was still growing even though the first sales boost from these medicines is now in the base. "Growth is encouraging as we have now cycled the initial structural uplift from the introduction of GLP-1 sales," Managing Director and Chief Executive Vikesh Ramsunder said.
Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s
October 21, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The industry walked out on Britain, and what it cost to win them back
October 22, 2026 - - Latest News -
BioNTech opens mRNA plant, putting Melbourne's north on the biotech map
October 22, 2026 - - Latest News -
An architect of the first industry–Commonwealth medicines pact to lead CSL
October 21, 2026 - - Latest News -
Quarterly update shows Telix holds course for a US$1 billion milestone year
October 21, 2026 - - Latest News -
Chemist Warehouse keeps growing as Sigma sets its sights on oral GLP-1s
October 21, 2026 - - Latest News -
America's ever rising GLP-1 curve and how Australia is following
October 21, 2026 - - Latest News -
Patient groups across Asia-Pacific push for a say on medicine prices
October 21, 2026 - - Latest News
